SnagRx vs BreezeMeds: Compounded Pricing, Product Types, Speed
Quick verdict: SnagRx favors cost-conscious patients with a locked annual compounded plan, while BreezeMeds offers injectable and oral GLP-1 options with higher listed starting prices and less visible fee detail.
See SnagRx pricing and plan details
SnagRx vs BreezeMeds: what stands out
This comparison of SnagRx vs BreezeMeds focuses on five distinctive differences supported by the sources: pricing structure and commitments, product types and FDA status, transparency about pharmacies and clinicians, approval and shipping timelines, and guarantees and fees. The primary keyword appears here to keep search intent clear.
1. Pricing structure and commitments
SnagRx advertises compounded semaglutide from $69/month and tirzepatide from $119/month on a 12-month plan, with the rate “locked flat at every dose” for the life of treatment. Month-to-month equivalents are $99 and $149, and the low figures require the 12-month plan. BreezeMeds displays “starting at” prices such as semaglutide injection from $199/month and tirzepatide injection from $299, plus oral options from $399, while a separate $169 figure appears without clear product association. The sources show SnagRx ties its lowest rates to a 12-month commitment and an explicit price-lock; BreezeMeds lists multiple starting prices and does not supply full billing visibility in the captured evidence.
Compare SnagRx annual plan pricing
2. Product types and regulatory notes
SnagRx is described as offering compounded semaglutide and compounded tirzepatide only. The source explicitly notes compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. BreezeMeds advertises injectable and oral options: semaglutide injection, tirzepatide injection, oral semaglutide and oral tirzepatide. Its captured evidence states medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable. Both providers require clinician review to determine medical appropriateness.
Check BreezeMeds available medication options
3. Transparency: named partners and clinician networks
SnagRx names its four US 503A partner pharmacies and its clinician network, OpenLoop Health, and states LegitScript certification. The source notes OpenLoop Health clinicians cover 48 states and that named pharmacies are used to fill compounded prescriptions. BreezeMeds provides less captured detail about pharmacy partners or clinician network names; the guidance in the source is to confirm eligibility, medication, total cost, renewal terms and state availability before enrollment.
4. Approval speed and shipping
SnagRx states an intake takes about five minutes, an OpenLoop clinician typically reviews it within five hours and always within 24, and approved orders ship next-day via UPS or FedEx in discreet, temperature-controlled packaging. BreezeMeds markets discreet home delivery but the captured evidence does not provide specific review or shipping timeframes.
5. Guarantees, refunds and billing clarity
SnagRx’s source mentions a full refund if the prescription is declined and a 6-month weight-loss guarantee with terms that apply. The source also highlights “no hidden fees” and “no monthly membership” claims for SnagRx. For BreezeMeds the source notes fees and billing commitments were not fully visible in captured content and recommends confirming costs and terms before enrolling.
Comparison table: SnagRx vs BreezeMeds
| Criteria | SnagRx | BreezeMeds |
|---|---|---|
| Starting price | Compounded semaglutide from $69/month on 12-month plan; month-to-month $99 | Semaglutide injection starting at $199/month; tirzepatide injection $299; oral options from $399 |
| Price structure | Price locked flat at every dose for life on annual plan | “Starting at” pricing shown; billing terms not fully visible in captured evidence |
| Product types | Compounded semaglutide and tirzepatide only | Injectable and oral GLP-1 options listed |
| Pharmacies and clinicians | Names four US 503A partner pharmacies and OpenLoop Health clinician network | No named pharmacies or clinician network captured; states and eligibility to confirm |
| Approval and shipping | Intake ~5 minutes; clinician review typically within 5 hours; next-day UPS/FedEx shipping | Discreet home delivery advertised; specific review and shipping times not supplied |
| Regulatory note | Compounded medications not FDA-approved | Medication-specific approval status must be confirmed; branded and compounded products not interchangeable |
How to choose: final guidance on SnagRx vs BreezeMeds
Choose SnagRx if you want compounded semaglutide from $69/month on a 12-month plan with a price locked flat at every dose, named US 503A pharmacies, an OpenLoop Health clinician network, and stated next-day shipping and refund terms.
Start SnagRx enrollment and view requirements
Choose BreezeMeds if you need injectable or oral GLP-1 options listed together and want to confirm specific product availability, total cost, renewal terms and state eligibility before enrolling; the source lists semaglutide and tirzepatide in both injectable and oral forms with starting prices shown.
Review BreezeMeds medication and eligibility info
In short, SnagRx focuses on lower locked annual compounded pricing and named partners, while BreezeMeds presents multiple delivery formats and higher starting prices where you should confirm terms. For searches about SnagRx vs BreezeMeds, use these provider details to match the option to your priorities.